FDA Adverse Event Injury Summary report: N

WATCHMAN FLX PRO LAA CLOSURE DEVICE WITH DELIVERY SYSTEM

MDR report key: 19776830 · Received July 18, 2024

Report

Report Number
2124215-2024-44333
Event Type
Injury
Date Received
July 18, 2024
Date of Event
July 15, 2024
Report Date
July 29, 2024
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
NGV
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CO, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

B5: INFORMATION ADDED. B7: INFORMATION ADDED.

Description of Event or Problem · 0

IT WAS REPORTED THAT THROMBOSIS OCCURRED. A LEFT ATRIAL APPENDAGE (LAA) CLOSURE PROCEDURE WAS PERFORMED AND A 35MM WATCHMAN FLX PRO CLOSURE DEVICE WAS IMPLANTED. THE PATIENT WAS PLACED ON ELIQUIS AND ASPIRIN ORAL ANTICOAGULANT (OAC) MEDICATION REGIMEN. AT THE 45 DAY ROUTINE FOLLOW UP, TRANSESOPHAGEAL ECHOCARDIOGRAM (TEE) REVEALED A DEVICE RELATED THROMBUS (DRT) ON THE THREADED INSERT OF THE CLOSURE DEVICE. THE PHYSICIANS PLACED THE PATIENT BACK ON ELIQUIS MEDICATION AND WILL DO A FOLLOW UP TEE IN THREE MONTHS IN RESPONSE TO THE DRT.

Description of Event or Problem · 0

IT WAS REPORTED THAT THROMBOSIS OCCURRED. A LEFT ATRIAL APPENDAGE (LAA) CLOSURE PROCEDURE WAS PERFORMED AND A 35MM WATCHMAN FLX PRO CLOSURE DEVICE WAS IMPLANTED. THE PATIENT WAS PLACED ON ELIQUIS AND ASPIRIN ORAL ANTICOAGULANT (OAC) MEDICATION REGIMEN. AT THE 45-DAY ROUTINE FOLLOW UP, TRANSESOPHAGEAL ECHOCARDIOGRAM (TEE) REVEALED A DEVICE RELATED THROMBUS (DRT) ON THE THREADED INSERT OF THE CLOSURE DEVICE. THE PHYSICIANS PLACED THE PATIENT BACK ON ELIQUIS MEDICATION AND WILL DO A FOLLOW UP TEE IN THREE MONTHS IN RESPONSE TO THE DRT. IT WAS FURTHER REPORTED THAT THE OAC REGIMEN CONSISTED OF PLAVIX AND ASPIRIN POST INDEX PROCEDURE, AND THE PATIENT REPORTED BEING COMPLIANT. THE DRT WAS LAMINAR IN NATURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1962089 WATCHMAN FLX PRO LAA CLOSURE DEVICE WITH DELIVERY SYSTEM SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL NGV BOSTON SCIENTIFIC CORPORATION WS6035 0033704671

Patients

Seq Age Sex Outcome Treatment
1 87 YR Female Required Intervention